Announced
Completed
Esco Lifesciences completed the spin-off of Esco Aster.
Financials
Transaction Value-
Consideration Type-
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-
Sources
Tags
Singapore
contract research
Single Bidder
Friendly
Biotechnology
Completed
Majority
Private
Demerger
Domestic
Spin Off
Synopsis
Esco Lifesciences, a life science company, completed the spin-off of Esco Aster, a vertically-integrated contract research organization. Financial terms were not disclosed.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.